IDOXURIDINE

PRODUCT IDENTIFICATION

CAS NO. 54-42-2

IDOXURIDINE 

EINECS NO. 200-207-8
FORMULA C9H11IN2O5
MOL WT. 354.10

H.S. CODE

2933.99.9700

TOXICITY

Oral  mouse LD50: > 10,000 mg/kg

SYNONYMS Idoxuridine; 2'-Deoxy-5-iodouridine; 5-IUdR;

1-(2-Deoxy-beta-D-ribofuranosyl)-5-iodouracil; 1-beta-D-2'-Deoxyribofuranosyl-5-iodouracil; 1beta-D-2'-Deoxyribofuranosyl-5-iodouracil; 2'-Deoxy-5-iodouridine; 5-IUDR; 5-Iodo-2'-deoxyuridine; 5-Iododeoxyuridine; 5-Iodouracil deoxyriboside; 5IUDR; Antizona; Herplex; IDU; IDUR; IUDR; Idexur; Idossuridina; Idoxene; Idoxuridin; Idoxuridina; Idoxuridine; Idoxuridinum; Iduviran; Iododeoxyridine; Iodoxuridine; Joddeoxiuridin; Ophthalmadine; Spectanefran; Stoxil; Virudox; 1-(2-Deoxy-beta-D-ribofuranosyl)-5-iodouracil; Other RN: 888-04-0, 1336-77-2

SMILES n1([C@@H]2O[C@H](CO)[C@H](C2)O)c([nH]c(=O)c(c1)I)=O

CLASSIFICATION

Anti-Infective, Antiviral, Nucleoside

EXTRA NOTES

An analog of deoxyuridine that inhibits viral DNA synthesis. The drug is used as an antiviral agent.

PHYSICAL AND CHEMICAL PROPERTIES

PHYSICAL STATE white crystalline powder
MELTING POINT 263 C
BOILING POINT  
SPECIFIC GRAVITY  
SOLUBILITY IN WATER 2000 mg/l
pH  
VAPOR DENSITY

 

AUTOIGNITION

 

log P -0.98 (Octanol-water)
VAPOR PRESSURE 1.07E-15 (mmHg at 25 C)
HENRY LAW CONSTANT 9.71E-19 (atm-m3/mole at 25 C)
OH RATE CONSTANT 6.82E-11 (cm3/molecule-sec at 25 C Atmospheric)

NFPA RATINGS

Health: 2, Flammability: 0, Reactivity: 0

REFRACTIVE INDEX

 
FLASH POINT

 

STABILITY Stable under ordinary conditions.

EXTERNAL LINKS & GENERAL DESCRIPTION

Wikipedia Linking

Google Scholar Search

Drug Information Portal (U.S. National Library of Medicine) - Idoxuridine

PubChem Compound Summary - Idoxuridine

Drug Bank - Idoxuridine

KEGG (Kyoto Encyclopedia of Genes and Genomes) -  S-Adenosylmethionine

http://www.cancernewsnetwork.org/
Pharmacology and use: In chemical structure idoxuridine closely approximates the configuration of thymidine, one of the four building blocks of DNA (the genetic material of the Herpes virus). As a result, idoxuridine is able to replace thymidine in the enzymatic step of viral replication or "growth". The consequent production of faulty DNA results in a pseudostructure which cannot infect or destroy tissue. In short, by pre-empting a vital building block in the genetic material of the Herpes simplex virus, Herplex-D topical solution destroys the infective and destructive capacity of the viral material. The virus infected cell may only be attacked during the period of active synthesis of DNA. This occurs early in the development of the Herpes simplex lesion, but at different times in different cells. Therefore, ideally, the affected area should remain saturated with the antiviral agent. For use in keratoconjunctivitis and keratitis caused by herpes simplex virus

http://www.ncbi.nlm.nih.gov/
Determination of 2'-deoxy-5-iodouridine and its metabolite 5-iodouracil by high-performance liquid chromatography with ultraviolet absorbance detection in human serum.

SALES SPECIFICATION

APPEARANCE

white crystalline powder

IDENTIFICATION

passes Test IR, UV

TOTAL CONTENT

99.0% min

SPECIFIC ROTATION

28° ~ 31°

LOSS ON DRYING

0.5% max

ASH

0.3% max

pH

1.0 - 2.0

HEAVY METALS

10ppm max

TRANSPORTATION
PACKING

 

HAZARD CLASS  
UN NO. Not regulated
SAFETY INFORMATION

Hazard OVERVIEW

Light sensitive. OSHA Hazards:Target Organ Effect, Irritant, Teratogen, Mutagen. Target Organs:Bone marrow, Gastrointestinal tract

GHS

 

SIGNAL WORD

PICTOGRAMS

None

HAZARD STATEMENTS

H315 Causes skin irritation.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
H341 Suspected of causing genetic defects.
H361 Suspected of damaging fertility or the unborn child.

PRECAUTIONARY STATEMENTS

P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
P281 Use personal protective equipment as required.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

EC DIRECTIVES

 

HAZARD CODES

T Toxic

RISK PHRASES

36/37/38  Irritating to eyes, respiratory system and skin.
63  Possible risk of harm to the unborn child.
68  Possible risks of irreversible effects.

SAFETY PHRASES

26  In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
36/37/39  Wear suitable protective clothing, gloves and eye/face protection.

PRICE INFORMATION